In an endometrial tumor cell model, G36 greatly reduces growth of estrogen-stimulated cells, suggesting that GPR30 may play a critical role in endometrial carcinogenesis and, therefore, providing G36 as a novel target for prognosis and treatment [49]. The gene discussed is GPER1; the disease is endometrium neoplasm.